Calcitonin gene-related peptide receptor antagonists: Beyond migraine pain -a possible analgesic strategy for osteoarthritis? Topical collection on pain aspects of arthritis

Current Pain and Headache Reports

Volumn 17, Issue 11, 2013, Pages

  Bullock, C M ^a   Kelly, S ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

CGRP; CGRP receptor antagonists; Osteoarthritis; Pain; Peripheral sensitization

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; CALCITONIN GENE RELATED PEPTIDE[8-37]; OLCEGEPANT; ANALGESIC AGENT;

ANALGESIC ACTIVITY; ANTINOCICEPTION; ARTICLE; BLOOD BRAIN BARRIER; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG PENETRATION; DRUG TARGETING; HUMAN; MIGRAINE; NOCICEPTION; NONHUMAN; OSTEOARTHRITIS; PAIN RECEPTOR; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; MALE; METABOLISM; PAIN; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ANALGESICS; CALCITONIN GENE-RELATED PEPTIDE; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; NOCICEPTION; OSTEOARTHRITIS; PAIN; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; TREATMENT OUTCOME;

EID: 84887068426     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-013-0375-2     Document Type: Article

References (100)

1. Dray A, Read SJ. Arthritis and pain. Future targets to control osteoarthritis pain. Arthritis Res Ther. 2007;9:212. (Pubitemid 350162910)
2. Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10:287-333.
3. Kosek E, Ordeberg G. Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief. Pain. 2000;88:69-78.
4. Creamer P, Hunt M, Dieppe P. Pain mechanisms in osteoarthritis of the knee: effect of intraarticular anesthetic. J Rheumatol. 1996;23:1031-6. (Pubitemid 26196094)
5. •• Arendt-Nielsen L, Nie H, Laursen MB, et al. Sensitization in patients with painful knee osteoarthritis. Pain. 2010;149:573-81. Demonstration of peripheral sensitization in patients with osteoarthritis.
6. Fernihough J, Gentry C, Bevan S, et al. Regulation of calcitonin gene-related peptide and TRPV1 in a rat model of osteoarthritis. Neurosci Lett. 2005;388:75-80. (Pubitemid 41206735)
7. Doods H, Arndt K, Rudolf K, et al. CGRP antagonists: unravelling the role of CGRP in migraine. Trends Pharmacol Sci. 2007;28:580-7. (Pubitemid 350026615)
8. Amara SG, Jonas V, Rosenfeld MG, et al. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature. 1982;298:240-4. (Pubitemid 12089405)
9. Steenbergh PH, Hoppener JW, Zandberg J, et al. A second human calcitonin/CGRP gene. FEBS Lett. 1985;183:403-7. (Pubitemid 15042761)
10. Mulderry PK, Ghatei MA, Spokes RA, et al. Differential expression of alpha-CGRP and beta-CGRP by primary sensory neurons and enteric autonomic neurons of the rat. Neuroscience. 1988;25:195-205.
11. Brain SD, Williams TJ, Tippins JR, et al. Calcitonin gene-related peptide is a potent vasodilator. Nature. 1985;313:54-6. (Pubitemid 15192304)
12. Cambridge H, Brain SD. Calcitonin gene-related peptide increases blood flow and potentiates plasma protein extravasation in the rat knee joint. Br J Pharmacol. 1992;106:746-50.
13. • Hirsch S, Corradini L, Just S, et al. The CGRP receptor antagonist BIBN4096BS peripherally alleviates inflammatory pain in rats. Pain. 2013;154:700-7. First study to demonstrate alleviation of pain in an animal model of OA by a CGRP receptor antagonist.
14. McCarthy PW, Lawson SN. Cell type and conduction velocity of rat primary sensory neurons with calcitonin gene-related peptide-like immunoreactivity. Neuroscience. 1990;34:623-32. (Pubitemid 20146726)
15. Lee Y, Takami K, Kawai Y, et al. Distribution of calcitonin gene-related peptide in the rat peripheral nervous system with reference to its coexistence with substance P. Neuroscience. 1985;15:1227-37. (Pubitemid 15226679)
16. Lawson SN, Crepps B, Perl ER. Calcitonin gene-related peptide immunoreactivity and afferent receptive properties of dorsal root ganglion neurones in guinea-pigs. J Physiol. 2002;540:989-1002. (Pubitemid 35190168)
17. Gibson S, Polak J, Bloom S, et al. Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. J Neurosci. 1984;4:3101-11. (Pubitemid 15191179)
18. Morton CR, Hutchison WD. Release of sensory neuropeptides in the spinal cord: studies with calcitonin gene-related peptide and galanin. Neuroscience. 1989;31:807-15. (Pubitemid 20032967)
19. Sauer SK, Bove GM, Averbeck B, et al. Rat peripheral nerve components release calcitonin gene-related peptide and prostaglandin E2 in response to noxious stimuli: evidence that nervi nervorum are nociceptors. Neuroscience. 1999;92:319-25. (Pubitemid 29249041)
20. Puttfarcken PS, Han P, Joshi SK, et al. A-995662 [(R)-8-(4-methyl-5-(4- (trifluoromethyl)phenyl)oxazol-2-ylamino)-1,2,3,4-te trahydronaphthalen-2-ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain model. Pain. 2010;150:319-26.
21. Schaible HG, Freudenberger U, Neugebauer V, et al. Intraspinal release of immunoreactive calcitonin gene-related peptide during development of inflammation in the joint in vivo - a study with antibody microprobes in cat and rat. Neuroscience. 1994;62:1293-305. (Pubitemid 24335619)
22. • Ogbonna AC, Clark AK, Gentry C, et al. Pain-like behaviour and spinal changes in the monosodium iodoacetate model of osteoarthritis in C57Bl/6 mice. Eur J Pain. 2013;17:514-26. Demonstrated reduced mechanical allodynia in an animal model of OA following administration of an intrathecal CGRP receptor antagonist.
23. Kessler F, Habelt C, Averbeck B, et al. Heat-induced release of CGRP from isolated rat skin and effects of bradykinin and the protein kinase C activator PMA. Pain. 1999;83:289-95. (Pubitemid 29479288)
24. Kangrga I, Larew JSA, Randic M. The effects of substance P and calcitonin gene-related peptide on the efflux of endogenous glutamate and aspartate from the rat spinal dorsal horn in vitro. Neurosci Lett. 1990;108:155-60. (Pubitemid 20036448)
25. Quirion R, Van Rossum D, Dumont Y, et al. Characterization of CGRP1 and CGRP2 Receptor Subtypesa. Ann N Y Acad Sci. 1992;657:88-105.
26. Aiyar N, Rand K, Elshourbagy NA, et al. A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J Biol Chem. 1996;271:11325-9. (Pubitemid 26155969)
27. McLatchie LM, Fraser NJ, Main MJ, et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 1998;393:333-9. (Pubitemid 28269699)
28. Hay DL, Howitt SG, Conner AC, et al. CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS. Br J Pharmacol. 2003;140:477-86. (Pubitemid 37330492)
29. Evans BN, Rosenblatt MI, Mnayer LO, et al. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem. 2000;275:31438-43.
30. Walker CS, Conner AC, Poyner DR, et al. Regulation of signal transduction by calcitonin gene-related peptide receptors. Trends Pharmacol Sci. 2010;31:476-83.
31. Brain SD, Grant AD. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev. 2004;84:903-34. (Pubitemid 38823770)
32. Parameswaran N, Disa J, Spielman WS, et al. Activation of multiple mitogen-activated protein kinases by recombinant calcitonin gene-related peptide receptor. Eur J Pharmacol. 2000;389:125-30. (Pubitemid 30109400)
33. Drissi H, Lasmoles F, Le Mellay V, et al. Activation of phospholipase C-beta1 via Galphaq/11 during calcium mobilization by calcitonin gene-related peptide. J Biol Chem. 1998;273:20168-74. (Pubitemid 28377575)
34. Sun RQ, Tu YJ, Lawand NB, et al. Calcitonin gene-related peptide receptor activation produces PKA- and PKC-dependent mechanical hyperalgesia and central sensitization. J Neurophysiol. 2004;92:2859-66. (Pubitemid 40340497)
35. Chakravarty P, Suthar TP, Coppock HA, et al. CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) in rat tissues. Br J Pharmacol. 2000;130:189-95. (Pubitemid 30248444)
36. Ma W, Chabot JG, Powell KJ, et al. Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems. Neuroscience. 2003;120:677-94. (Pubitemid 36928066)
37. Cottrell GS, Alemi F, Kirkland JG, et al. Localization of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1) in human gastrointestinal tract. Peptides. 2012;35:202-211.
38. Cottrell GS, Roosterman D, Marvizon J-C, et al. Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat. J Comp Neurol. 2005;490:239-55. (Pubitemid 41140991)
39. Pokabla MJ, Dickerson IM, Papka RE. Calcitonin gene-related peptide-receptor component protein expression in the uterine cervix, lumbosacral spinal cord, and dorsal root ganglia. Peptides. 2002;23:507-14. (Pubitemid 34143267)
40. Zhang Z, Winborn CS, Marquez de Prado B, et al. Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci. 2007;27:2693-703. (Pubitemid 46393588)
41. Rosenfeld MG, Mermod JJ, Amara SG, et al. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature. 1983;304:129-35. (Pubitemid 13079138)
42. Han JS, Adwanikar H, Li Z, et al. Facilitation of synaptic transmission and pain responses by CGRP in the amygdala of normal rats. Mol Pain. 2010;6:10.
43. Han JS, Li W, Neugebauer V. Critical role of calcitonin gene-related peptide 1 receptors in the amygdala in synaptic plasticity and pain behavior. J Neurosci. 2005;25:10717-28. (Pubitemid 41681920)
44. Xu W, Lundeberg T, Wang YT, et al. Antinociceptive effect of calcitonin gene-related peptide in the central nucleus of amygdala: activating opioid receptors through amygdala-periaqueductal gray pathway. Neuroscience. 2003;118:1015-22. (Pubitemid 36561189)
45. Adwanikar H, Ji G, Li W, et al. Spinal CGRP1 receptors contribute to supraspinally organized pain behavior and pain-related sensitization of amygdala neurons. Pain. 2007;132:53-66. (Pubitemid 47494558)
46. Li N, Lundeberg T, Yu LC. Involvement of CGRP and CGRP1 receptor in nociception in the nucleus accumbens of rats. Brain Res. 2001;901:161-6. (Pubitemid 32718818)
47. Huang Y, Brodda-Jansen G, Lundeberg T, et al. Anti-nociceptive effects of calcitonin gene-related peptide in nucleus raphe magnus of rats: an effect attenuated by naloxone. Brain Res. 2000;873:54-9. (Pubitemid 30468485)
48. Yu LC, Weng XH, Wang JW, et al. Involvement of calcitonin gene-related peptide and its receptor in anti-nociception in the periaqueductal grey of rats. Neurosci Lett. 2003;349:1-4. (Pubitemid 37289256)
49. Pecile A, Guidobono F, Netti C, et al. Calcitonin gene-related peptide: antinociceptive activity in rats, comparison with calcitonin. Regul Pept. 1987;18:189-99. (Pubitemid 17138591)
50. Leem JW, Gwak YS, Lee EH, et al. Effects of iontophoretically applied substance P, calcitonin gene-related peptide on excitability of dorsal horn neurones in rats. Yonsei Med J. 2001;42:74-83.
51. Bird G, Han J, Fu Y, et al. Pain-related synaptic plasticity in spinal dorsal horn neurons: role of CGRP. Mol Pain. 2006;2:31. (Pubitemid 44541904)
52. Miletic V, Tan H. Iontophoretic application of calcitonin gene-related peptide produces a slow and prolonged excitation of neurons in the cat lumbar dorsal horn. Brain Res. 1988;446:169-72. (Pubitemid 18091762)
53. Yu Y, Lundeberg T, Yu LC. Role of calcitonin gene-related peptide and its antagonist on the evoked discharge frequency of wide dynamic range neurons in the dorsal horn of the spinal cord in rats. Regul Pept. 2002;103:23-7. (Pubitemid 34001633)
54. Oku R, Satoh M, Fujii N, et al. Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain Res. 1987;403:350-4. (Pubitemid 17019718)
55. Cridland RA, Henry JL. Effects of intrathecal administration of neuropeptides on a spinal nociceptive reflex in the rat: VIP, galanin, CGRP, TRH, somatostatin and angiotensin II. Neuropeptides. 1988;11:23-32. (Pubitemid 18036888)
56. Kawamura M, Kuraishi Y, Minami M, et al. Antinociceptive effect of intrathecally administered antiserum against calcitonin gene-related peptide on thermal and mechanical noxious stimuli in experimental hyperalgesic rats. Brain Res. 1989;497:199-203. (Pubitemid 19219931)
57. Yu L-C, Hansson P, Lundeberg T. The calcitonin gene-related peptide antagonist CGRP8-37 increases the latency to withdrawal responses in rats. Brain Res. 1994;653:223-30. (Pubitemid 24252842)
58. Gamse R, Saria A. Nociceptive behavior after intrathecal injections of substance P, neurokinin A and calcitonin gene-related peptide in mice. Neurosci Lett. 1986;70:143-7. (Pubitemid 16023254)
59. Segond von Banchet G, Pastor A, Biskup C, et al. Localization of functional calcitonin gene-related peptide binding sites in a subpopulation of cultured dorsal root ganglion neurons. Neuroscience. 2002;110:131-45. (Pubitemid 34214765)
60. Natura G, von Banchet GS, Schaible HG. Calcitonin gene-related peptide enhances TTX-resistant sodium currents in cultured dorsal root ganglion neurons from adult rats. Pain. 2005;116:194-204. (Pubitemid 40957122)
61. Schaible HG, Schmidt RF. Excitation and sensitization of fine articular afferents from cat's knee joint by prostaglandin E2. J Physiol. 1988;403:91-104.
62. Birrell GJ, McQueen DS, Iggo A, et al. PGI2-induced activation and sensitization of articular mechanonociceptors. Neurosci Lett. 1991;124:5-8.
63. Wang H, Ehnert C, Brenner GJ, et al. Bradykinin and peripheral sensitization. Biol Chem. 2006;387:11-4. (Pubitemid 43089589)
64. Mogil JS, Miermeister F, Seifert F, et al. Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene. Proc Natl Acad Sci. 2005;102:12938-43. (Pubitemid 41279468)
65. Shi X, Wang L, Li X, et al. Neuropeptides contribute to peripheral nociceptive sensitization by regulating interleukin-1beta production in keratinocytes. Anesth Analg. 2011;113:175-83.
66. Nakamura-Craig M, Gill BK. Effect of neurokinin A, substance P and calcitonin gene related peptide in peripheral hyperalgesia in the rat paw. Neurosci Lett. 1991;124:49-51.
67. Ferrari LF, Bogen O, Levine JD. Nociceptor subpopulations involved in hyperalgesic priming. Neuroscience. 2010;165:896-901.
68. Sun RQ, Lawand NB, Lin Q, et al. Role of calcitonin gene-related peptide in the sensitization of dorsal horn neurons to mechanical stimulation after intradermal injection of capsaicin. J Neurophysiol. 2004;92:320-6. (Pubitemid 38802254)
69. Yan Y, Yu LC. Involvement of opioid receptors in the CGRP8-37-induced inhibition of the activity of wide-dynamic-range neurons in the spinal dorsal horn of rats. J Neurosci Res. 2004;77:148-52. (Pubitemid 38850065)
70. Lofgren O, Yu LC, Theodorsson E, et al. Intrathecal CGRP(8-37) results in a bilateral increase in hindpaw withdrawal latency in rats with a unilateral thermal injury. Neuropeptides. 1997;31:601-7. (Pubitemid 28037476)
71. Kuraishi Y, Nanayama T, Ohno H, et al. Antinociception induced in rats by intrathecal administration of antiserum against calcitonin gene-related peptide. Neurosci Lett. 1988;92:325-9.
72. Bowler KE, Worsley MA, Broad L, et al. Evidence for anti-inflammatory and putative analgesic effects of a monoclonal antibody to calcitonin gene-related peptide. Neuroscience. 2013;228:271-82.
73. Eftekhari S, Edvinsson L. Possible sites of action of the new calcitonin gene-related peptide receptor antagonists. Ther Adv Neurol Disord. 2010;3:369-78.
74. Goadsby PJ, Charbit AR, Andreou AP, et al. Neurobiology of migraine. Neuroscience. 2009;161:327-41.
75. Uddman R, Edvinsson L, Ekman R, et al. Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett. 1985;62:131-6. (Pubitemid 16205735)
76. Fischer MJM. Calcitonin gene-related peptide receptor antagonists for migraine. Expet Opin Investig Drugs. 2010;19:815-23.
77. Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol. 1988;23:193-6. (Pubitemid 18081459)
78. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28:183-7. (Pubitemid 20244522)
79. Lassen L, Haderslev P, Jacobsen V, et al. Cgrp may play a causative role in migraine. Cephalalgia. 2002;22:54-61. (Pubitemid 34626025)
80. Olesen J, Diener HC, Husstedt IW, et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med. 2004;350:1104-10. (Pubitemid 38298990)
81. Ho TW, Mannix LK, Fan X, et al. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology. 2008;70:1304-12. (Pubitemid 351550355)
82. Fischer MJ, Koulchitsky S, Messlinger K. The nonpeptide calcitonin gene-related peptide receptor antagonist BIBN4096BS lowers the activity of neurons with meningeal input in the rat spinal trigeminal nucleus. J Neurosci. 2005;25:5877-83. (Pubitemid 40911418)
83. Kulchitsky S, Fischer M, Messlinger K. Calcitonin gene-related peptide receptor inhibition reduces neuronal activity induced by prolonged increase in nitric oxide in the rat spinal trigeminal nucleus. Cephalalgia. 2009;29:408-17.
84. Storer RJ, Akerman S, Goadsby PJ. Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol. 2004;142:1171-81. (Pubitemid 39093014)
85. Doods H, Hallermayer G, Wu D, et al. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol. 2000;129:420-3. (Pubitemid 30083862)
86. Ahmed AS, Li J, Erlandsson-Harris H, et al. Suppression of pain and joint destruction by inhibition of the proteasome system in experimental osteoarthritis. Pain. 2012;153:18-26.
87. Ashraf S, Wibberley H, Mapp PI, et al. Increased vascular penetration and nerve growth in the meniscus: a potential source of pain in osteoarthritis. Ann Rheum Dis. 2011;70:523-9.
88. Saxler G, Loer F, Skumavc M, et al. Localization of SP- and CGRP-immunopositive nerve fibers in the hip joint of patients with painful osteoarthritis and of patients with painless failed total hip arthroplasties. Eur J Pain. 2007;11:67-74. (Pubitemid 44636277)
89. Saito T, Koshino T. Distribution of neuropeptides in synovium of the knee with osteoarthritis. Clin Orthop Relat Res. 2000;376:172-82. (Pubitemid 30445693)
90. Orita S, Ishikawa T, Miyagi M, et al. Pain-related sensory innervation in monoiodoacetate-induced osteoarthritis in rat knees that gradually develops neuronal injury in addition to inflammatory pain. BMC Musculoskelet Disord. 2011;12:134.
91. Ferreira-Gomes J, Adaes S, Sarkander J, et al. Phenotypic alterations of neurons that innervate osteoarthritic joints. Arthritis Rheum. 2010;62:3677-3685.
92. Kalff KM, El Mouedden M, van Egmond J, et al. Pre-treatment with capsaicin in a rat osteoarthritis model reduces the symptoms of pain and bone damage induced by monosodium iodoacetate. Eur J Pharmacol. 2010;641:108-13.
93. Marshall KW, Theriault E, Homonko DA. Distribution of substance P and calcitonin gene related peptide immunoreactivity in the normal feline knee. J Rheumatol. 1994;21:883-9. (Pubitemid 24168674)
94. Schwab W, Bilgicyildirim A, Funk RH. Microtopography of the autonomic nerves in the rat knee: a fluorescence microscopic study. Anat Rec. 1997;247:109-18. (Pubitemid 27418232)
95. Guzman R, Evans M, Bove S, et al. Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol Pathol. 2003;31:619-24. (Pubitemid 37433471)
96. Fernihough J, Gentry C, Malcangio M, et al. Pain related behaviour in two models of osteoarthritis in the rat knee. Pain. 2004;112:83-93. (Pubitemid 39371023)
97. Ivanavicius S, Ball A, Heapy C, et al. Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: increased expression of ATF-3 and pharmacological characterisation. Pain. 2007;128:272-82. (Pubitemid 46394533)
98. Bove S, Calcaterra S, Brooker R, et al. Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthr Cartil. 2003;11:821-30. (Pubitemid 37407598)
99. Kelly S, Dunham JP, Murray F, et al. Spontaneous firing in C-fibers and increased mechanical sensitivity in A-fibers of knee joint-associated mechanoreceptive primary afferent neurones during MIA-induced osteoarthritis in the rat. Osteoarthr Cartil. 2012;20:305-13.
100. Schuelert N, McDougall JJ. Involvement of Nav 1.8 sodium ion channels in the transduction of mechanical pain in a rodent model of osteoarthritis. Arthritis Res Ther. 2012;14:R5.